BD 1060 | 138356-10-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: BD 1060
• 英文别名: [2-(3,4-Dichloro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine；2-(3,4-dichlorophenyl)-N-(2-pyrrolidin-1-ylethyl)ethanamine
• CAS: 138356-10-2
• 化学式: C₁₄H₂₀Cl₂N₂
• mdl: MFCD26470889
• 分子量: 287.232
• InChiKey: KFLJZQLENAVFAL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  BD 1060 在 aluminium hydride 、 N,N'-二环己基碳二亚胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 氯仿 为溶剂， 反应 4.0h， 生成 N'-[2-(3,4-dichlorophenyl)ethyl]-N'-(2-pyrrolidin-1-ylethyl)ethane-1,2-diamine
  参考文献：
  名称：

  A new approach to the design of .sigma.-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine-related polyamines at .sigma.-1 and .sigma.-2 receptor subtypes

  摘要：

  A series of polyamines based on the high affinity sigma receptor ligand N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (3) were developed and evaluated for their binding characteristics at sigma-1 and sigma-2 receptor subtypes. The data indicated that a considerable degree of structural variation is possible while still retaining nanomolar affinity at a receptors; As the structure of the polyamines was varied, their binding at sigma-1 and sigma-2 subtypes showed quite different and in some cases opposite trends, supporting the belief that these are pharmacologically distinct entities. Polyamines containing two nitrogen atoms showed optimal binding at both sigma-1 and sigma-2 receptor subtypes. Although additional nitrogen atoms resulted in decreased affinity at sigma-1 and sigma-2 subtypes, an increase in selectivity for sigma-2 subtypes was evident; the parent 3 showed greater selectivity for sigma-1 subtypes. Internitrogen spacings had a large effect on binding affinity and subtype selectivity. For example, the difference between N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N,N'-dimethylethylenediamine (8) [K-i = 29.9 nM at sigma-1 receptor and 18.3 nM at alpha-2 receptor] to N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N/N'-dimethylethylenedi- amine (10) [K-i = 1.49 nM at sigma-1 receptor and 12.1 nM at sigma-2 receptor] illustrates the importance of internitrogen spacing. Triamines 11 and 13 [K-i(sigma-2)/K-i(sigma-1) = 0.19 and 0.10, respectively] containing the N-N-N-Ar spacings 3-3-2 and 4-4-2, proved to be the most sigma-2 subtype selective of the 15 polyamines examined in this study. The N-N-N spacings appear to be an important factor in their sigma-2 subtype selectivity. These compounds will serve as templates in the design of still further sigma-2 subtype selective ligands. The pyrrolidine ring (present in most of the polyamines tested in this series) proved to be an important recognition site for a receptor binding activity. Furthermore, alkyl substitution also appears to be important since the stripped down polyamines N-[2-(3,4-dichlorophenyl)ethyl]ethylenediamine (15) and N-1-[2-(3,4-dichlorophenyl)ethyl] diethylenetriamine (16) exhibited relatively low binding affinity.

  DOI：

  10.1021/jm00028a016
• 作为产物：
  描述：

  2-(3,4-dichlorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide 在 aluminium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 0.08h， 生成 BD 1060
  参考文献：
  名称：

  一类新型的N-（芳基乙基）-N-烷基-2-（1-吡咯烷基）乙胺的合成，表征和生物学评估：结构要求和对sigma受体的结合亲和力。

  摘要：

  通过合成和测试零件结构，N- [2-（3,4-二氯苯基）乙基] -N-甲基-2-（1-吡咯烷基）乙基胺（3）源自我们先前报道的高亲和力σ受体配体（1S，2R）-（-）-N- [2-（3,4-二氯苯基）-乙基] -N-甲基-2-（1-吡咯烷基）环己胺[（-）-2]和（+）-参见图2，我们已经鉴定出一类新型的对[3H]-（+）-3-PPP标记的σ受体具有特异性的超强（亚纳摩尔亲和力）σ配体。测试3从豚鼠脑膜置换[3H]-（+）-3-PPP的能力时，其Ki值为0.34 nM，优于其母体化合物（-）-2（Ki = 1.3 nM）和（+）-2（Ki = 6.0 nM）。与3相关的其他化合物，例如N- [2-（3,4-二氯苯基）乙基] -N-甲基-2-（1-高哌啶基）乙胺（19）的Ki = 0.17 nM [（3H]-（+ ）-3-PPP）。通过以多种不同方式操纵该结构来检查3的高sigma受体亲和力

  DOI：

  10.1021/jm00079a004

文献信息

• Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediamines as .sigma. receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes
  作者：Brian R. De Costa、Celia Dominguez、Xiao Shu He、Wanda Williams、Lilian Radesca、Wayne Bowen

  DOI：10.1021/jm00101a011

  日期：1992.11

  The synthesis and sigma receptor affinity of a series of conformationally restricted derivatives of 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenedi amine (1) is described. The pyrrolidinyl (or N,N-dialkyl),ethylenediamine,N-alkyl, and phenylethyl portions of this sigma receptor pharmacophore were restricted by its incorporation into 1,2-cyclohexanediamine-, pyrrolidine-, piperidine-

  描述了一系列2-（1-吡咯烷基）-N- [2-（3,4-二氯苯基）乙基] -N-甲基乙二胺（1）的构象受限衍生物的合成和sigma受体亲和力。该sigma受体药效基团的吡咯烷基（或N，N-二烷基），乙二胺，N-烷基和苯乙基部分受其并入1,2-环己烷二胺-，吡咯烷-，哌啶-，高哌啶-和四氢异喹啉-的限制。含有配体。使用[3H]（+）-喷他佐辛在豚鼠脑匀浆中测定这些化合物的sigma受体结合亲和力。除一类外，所有的合成都通过适当的二胺前体的酰化和烷烃还原来实现，该二胺前体的合成也已有报道。sigma受体亲和力范围为1.34 nM（对于6）（1R，2R）-反-N- [2-（3,4-二氯苯基）乙基] -N-甲基的7-二氯-2- [2-（1-（吡咯烷基）乙基]四氢异喹啉（12）至455 nM -2-（1-吡咯烷基）环己胺[（-）-4]。在该置换试验中，（+）-戊唑嗪的Ki值为3.1 nM，而DTG和氟哌啶醇的Ki值分别为27
• Synthesis and receptor binding properties of fluoro- and iodo-substituted high-affinity .sigma.-receptor ligands: identification of potential PET and SPECT .sigma.-receptor imaging agents
  作者：Brian De Costa、Lilian Radesca、Celia Dominguez、Lisa Di Paolo、Wayne D. Bowen

  DOI：10.1021/jm00090a012

  日期：1992.6

  second class of PET/SPECT ligands was based upon the N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamine class of sigma ligands; N-[2-(3,4-dichlorophenyl)-1-ethyl]-N-(3-fluoro-1-propyl)-2-(1- pyrrolidinyl)ethylamine (5) was obtained via N-alkylation of N-[2-(3,4-dichlorophenyl)-1-ethyl]-2-(1-pyrrolidinyl)ethylamine (14) with 3-fluoropropyl p-toluenesulfonate. 5 exhibited Ki values of 4.22 and 5.07 nM for

  基于三种不同的sigma受体配体结构类型，合成了未标记的对sigma受体具有很高亲和力和选择性的氟代和碘代取代基。评估这些化合物的sigma受体亲和力和特异性，以评估其作为PET / SPECT显像剂的潜力。因此，基于（+）-苯并吗啉类σ配体的（+）-和（-）-N-（5-氟-1-戊基）去甲甲恶嗪[[+]-和（-）-4]通过用5-[（甲基磺酰基）氧基] -1-戊基氟化物将光学纯的（+）-和（-）-去甲偶氮N烷基化（11）。（+）-和（-）-4取代的[3H]（+）-3-PPP的Ki值分别为0.29和73.6 nM和[3H]（+）-戊唑嗪的Ki值分别为10.5和38.9 nM。第二类PET / SPECT配体基于σ配体的N-（芳基乙基）-N-烷基-2-（1-吡咯烷基基）乙胺类；通过N-的N-烷基化获得N- [2-（3,4-二氯苯基）-1-乙基] -N-（3-氟-1-丙基）-2-（1-吡咯烷基）乙胺（5）。
• THERAPEUTICS AND METHODS OF TREATMENT OF ANGIOTENSIN-CONVERTING ENZYME 2 ASSOCIATED CONDITIONS
  申请人：Board of Supervisors of Louisiana State University and Agricultural and Mechanical College

  公开号：US20210379016A1

  公开（公告）日：2021-12-09

  Therapeutics and methods of treating one of an angiotensin-converting enzyme 2 (ACE2) associated condition and an ACE2 associated pre-condition patient comprising administering to the patient a pharmaceutically therapeutic dose of a therapeutic, wherein the therapeutic includes either a Sigmar1 antagonist or any pharmaceutically acceptable salt, solvate, or prodrug thereof, or a Sigmar1 enhancer, or any pharmaceutically acceptable salt, solvate, or prodrug thereof. A method of treating coronavirus disease 2019 (COVID-19) patient comprising administering to the patient a pharmaceutically therapeutic dose of a therapeutic, wherein the therapeutic includes a Sigmar1 enhancer, or any pharmaceutically acceptable salt, solvate, or prodrug thereof.
• [EN] N-(ARYLETHYL)-N-ALKYL-2-(1-PYRROLIDINYL)ETHYLAMINE DERIVATIVES FOR CNS DISORDERS
  申请人：——

  公开号：WO1992022279A2

  公开（公告）日：1992-12-23

  [FR] Sont décrits certains composés N-[aryléthyle]-N-alkyle-2-(1-pyrrolidinyle)-éthylamine utilisés pour le traitement des troubles du système nerveux central tels que l'ischémie cérébrale, les troubles psychologiques, les convulsions et la maladie de Parkinson. Les composés particulièrement intéressants sont de formule (I) où R1 est sélectionné dans le groupe hydrido, alkyle inférieur, cycloalkylalkyle de 4 à 6 atomes de carbone et alkényl inférieur alkyle; où R2 et R3 sont sélectionnés indépendamment dans le groupe hydrido et alkyle inférieur; où R4 à R9 sont sélectionnés indépendamment dans le groupe hydrido, hydroxyle, alkyle inférieur, benzyle, phénoxy, benzyloxy, et haloalkyle inférieur; où m est un nombre compris entre 1 et 3; où n est un nombre compris entre 4 et 7; où p est un nombre compris entre 0 et 4; où A est sélectionné dans le groupe phényle, naphtyle, et thyényl; où chacun des groupes A précédents peut être ensuite remplacé par un ou plusieurs substituants sélectionnés indépendamment dans le groupe hydrido, hydroxy, alkyle inférieur, alkoxy inférieur, halo, haloalkyle inférieur, amino, monoalkylamino inférieur et dialkylamino inférieur; ou un sel pharmaceutiquement acceptable.
• A new approach to the design of .sigma.-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine-related polyamines at .sigma.-1 and .sigma.-2 receptor subtypes
  作者：Brian R. de Costa、Xiao-shu He、Celia Dominguez、Janet Cutts、Wanda Williams、Wayne D. Bowen

  DOI：10.1021/jm00028a016

  日期：1994.1

  A series of polyamines based on the high affinity sigma receptor ligand N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (3) were developed and evaluated for their binding characteristics at sigma-1 and sigma-2 receptor subtypes. The data indicated that a considerable degree of structural variation is possible while still retaining nanomolar affinity at a receptors; As the structure of the polyamines was varied, their binding at sigma-1 and sigma-2 subtypes showed quite different and in some cases opposite trends, supporting the belief that these are pharmacologically distinct entities. Polyamines containing two nitrogen atoms showed optimal binding at both sigma-1 and sigma-2 receptor subtypes. Although additional nitrogen atoms resulted in decreased affinity at sigma-1 and sigma-2 subtypes, an increase in selectivity for sigma-2 subtypes was evident; the parent 3 showed greater selectivity for sigma-1 subtypes. Internitrogen spacings had a large effect on binding affinity and subtype selectivity. For example, the difference between N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N,N'-dimethylethylenediamine (8) [K-i = 29.9 nM at sigma-1 receptor and 18.3 nM at alpha-2 receptor] to N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N/N'-dimethylethylenedi- amine (10) [K-i = 1.49 nM at sigma-1 receptor and 12.1 nM at sigma-2 receptor] illustrates the importance of internitrogen spacing. Triamines 11 and 13 [K-i(sigma-2)/K-i(sigma-1) = 0.19 and 0.10, respectively] containing the N-N-N-Ar spacings 3-3-2 and 4-4-2, proved to be the most sigma-2 subtype selective of the 15 polyamines examined in this study. The N-N-N spacings appear to be an important factor in their sigma-2 subtype selectivity. These compounds will serve as templates in the design of still further sigma-2 subtype selective ligands. The pyrrolidine ring (present in most of the polyamines tested in this series) proved to be an important recognition site for a receptor binding activity. Furthermore, alkyl substitution also appears to be important since the stripped down polyamines N-[2-(3,4-dichlorophenyl)ethyl]ethylenediamine (15) and N-1-[2-(3,4-dichlorophenyl)ethyl] diethylenetriamine (16) exhibited relatively low binding affinity.